Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gluconeogenic enzyme PCK1 supports S-adenosylmethionine biosynthesis and promotes H3K9me3 modification to suppress hepatocellular carcinoma progression
Dongmei Gou, Rui Liu, Xiaoqun Shan, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 13
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Lactylation‐Driven IGF2BP3‐Mediated Serine Metabolism Reprogramming and RNA m6A—Modification Promotes Lenvatinib Resistance in HCC
Yuanxiang Lu, Jinghan Zhu, Yuxin Zhang, et al.
Advanced Science (2024)
Open Access | Times Cited: 14
Small-molecule-based targeted therapy in liver cancer
Ming Yue, Yanqiu Gong, Xuewen Fu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 10, pp. 3260-3287
Closed Access | Times Cited: 9
Methylomics and cancer: the current state of methylation profiling and marker development for clinical care
Chengyin Liu, Han Tang, Nana Hu, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 18
SETDB1: Progress and prospects in cancer treatment potential and inhibitor research
Tingnan Ma, Feifei Xu, Yingying Hou, et al.
Bioorganic Chemistry (2024) Vol. 145, pp. 107219-107219
Closed Access | Times Cited: 5
Gender Differences and miRNAs Expression in Cancer: Implications on Prognosis and Susceptibility
Santino Caserta, Sebastiano Gangemi, Giuseppe Murdaca, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11544-11544
Open Access | Times Cited: 13
Unlocking the potential of T‐cell metabolism reprogramming: Advancing single‐cell approaches for precision immunotherapy in tumour immunity
Lihaoyun Huang, Haitao Li, Cangang Zhang, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 5
Suv39h1 contributes to activation of hepatic stellate cells in non-alcoholic fatty liver disease by enabling anaerobic glycolysis
Xiaoyan Wu, Yuzhou Shen, Yufei Meng, et al.
Life Sciences (2024) Vol. 341, pp. 122498-122498
Closed Access | Times Cited: 4
Constructing a disulfidptosis-related prognostic signature of hepatocellular carcinoma based on single-cell sequencing and weighted co-expression network analysis
Zelin Tian, Junbo Song, Jiang She, et al.
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1632-1647
Closed Access | Times Cited: 4
Prolyl 4‐hydroxylase α‐subunit family regulation of type I collagen deposition and IL17RB/c‐Jun activation synergistically mediate choline dehydrogenase promotion of colorectal cancer metastasis
Xiaowen Yang, Yifei Li, Xinzhuang Shen, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access
Metabolic reprogramming of glucose: the metabolic basis for the occurrence and development of hepatocellular carcinoma
Kai Wang, Xiaodan Li, Shuwei Guo, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
BRD1 deficiency affects SREBF1-related lipid metabolism through regulating H3K9ac/H3K9me3 transition to inhibit HCC progression
Mingyang Zhang, Jing Bai, Hailong Yuan, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Inhibition of liver cancer cell growth by metabolites S-adenosylmethionine and nicotinic acid originating from liver progenitor cells
Wenming Liu, Cai–Yang Chen, Hong-Qian Ma, et al.
Journal of Gastroenterology (2025)
Open Access
Inhibition of Pck1 in intestinal epithelial cells alleviates acute pancreatitis via modulating intestinal homeostasis
Nuoming Yin, Binqiang Xu, Zehua Huang, et al.
The FASEB Journal (2024) Vol. 38, Iss. 8
Closed Access | Times Cited: 3
Crosstalk between Epigenetics and Metabolic Reprogramming in Metabolic Dysfunction-Associated Steatotic Liver Disease-Induced Hepatocellular Carcinoma: A New Sight
Anqi Li, Rui Wang, Yu-Qiang Zhao, et al.
Metabolites (2024) Vol. 14, Iss. 6, pp. 325-325
Open Access | Times Cited: 3
m6A-mediated gluconeogenic enzyme PCK1 upregulation protects against hepatic ischemia-reperfusion injury
Shanshan Yu, Xiao Liu, Yan Xu, et al.
Hepatology (2023)
Closed Access | Times Cited: 7
Research Progress on the Role of Epigenetic Methylation Modification in Hepatocellular Carcinoma
J Wang, Wenyue Gao, Hongbo Yu, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1143-1156
Open Access | Times Cited: 2
Hypoxia-induced circSTT3A enhances serine synthesis and promotes H3K4me3 modification to facilitate breast cancer stem cell formation
Ming Xu, Xiaoqi Liu, Xinyue Zhou, et al.
Pharmacological Research (2023) Vol. 197, pp. 106964-106964
Open Access | Times Cited: 5
Specific regulation of epigenome landscape by metabolic enzymes and metabolites
Xilan Yu, Shanshan Li
Biological reviews/Biological reviews of the Cambridge Philosophical Society (2024) Vol. 99, Iss. 3, pp. 878-900
Closed Access | Times Cited: 1
FLIM‐FRET‐based analysis of S100A11/annexin interactions in living cells
Christian Melle, Birgit Hoffmann, Annett Wiesenburg, et al.
FEBS Open Bio (2024) Vol. 14, Iss. 4, pp. 626-642
Open Access | Times Cited: 1
Role of HFSCARC in hair follicle stem cell proliferation and differentiation in cashmere goat
Niu Wang, Weidong Zhang, Yi Guo, et al.
Animal Research and One Health (2024) Vol. 2, Iss. 2, pp. 217-229
Open Access | Times Cited: 1
Inhibiting HMGCR represses stemness and metastasis of hepatocellular carcinoma via Hedgehog signaling
Zhirong Zhang, Jiayao Yang, Rui Liu, et al.
Genes & Diseases (2024) Vol. 11, Iss. 5, pp. 101285-101285
Open Access | Times Cited: 1
COMMON HUB GENES AND DRUG CANDIDATES FOR DIABETIC KIDNEY DISEASE AND NON-ALCOHOLIC FATTY LIVER DISEASE: A COMPREHENSIVE BIOINFORMATIC STUDY
K Datta
International Journal of Pharmaceutical Sciences and Drug Research (2024), pp. 102-109
Open Access | Times Cited: 1
Histone methylation modification and diabetic kidney disease: Potential molecular mechanisms and therapeutic approaches (Review)
Peng Qu, Lanfang Li, Qi Jin, et al.
International Journal of Molecular Medicine (2024) Vol. 54, Iss. 5
Closed Access | Times Cited: 1
SUV39H1 epigenetically modulates the MCPIP1-AURKA signaling axis to enhance neuroblastoma tumorigenesis
Mengzhen Li, Feifei Sun, Juan Wang, et al.
Oncogene (2024) Vol. 43, Iss. 45, pp. 3306-3320
Open Access | Times Cited: 1
Identification of target genes co-regulated by four key histone modifications of five key regions in hepatocellular carcinoma
Yu-Xian Liu, Jia‐Le Song, Xiaoming Li, et al.
Methods (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top